Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma

doi:10.12998/wjcc.v8.i19.4380

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5403)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

274

WORD

180

HTML

2203

Figures (1-2)

258

Tables (1-3)

230

Sum=3145

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

655

Download

1603

Sum=2258

Oct 6, 2020 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Oct 6, 2020; 8(19): 4380-4387
Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4380

Full Size Figure Download Figure

Figure 1 Comparison of cumulative recurrence-free survival and overall survival of patients with hepatocellular carcinoma treated with hepatic resection or percutaneous radiofrequency ablation. A: Cumulative recurrence-free survival; B: overall survival of patients. PRFA: Percutaneous radiofrequency ablation; HR: Hepatic resection.

Citation: Zhang YH, Su B, Sun P, Li RM, Peng XC, Cai J. Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma. World J Clin Cases 2020; 8(19): 4380-4387
URL: https://www.wjgnet.com/2307-8960/full/v8/i19/4380.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i19.4380